Drawing for SMAC

USPTO serial 50083918

SMAC

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with SMAC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua M. Gerben

Joshua M. Gerben Gerben Perrott, PLLC1050 Connecticut Ave. NW Suite 500Washington, DC 20036United States

Goods and services

ClassDescriptionStatusFirst use
035Market analysis and research services; Regulatory submission management and authoring, namely, assisting others in preparing and filing applications for new drugs, diagnostics or devices with governmental regulatory bodies; Business consultation and management regarding marketing activities and launching of new products; Analyzing and compiling business data for market research, healthcare insights, customer segmentation, stakeholder engagement, regulatory approval, and business reporting purposes; Business consulting services in the field of life sciences, pharmaceuticals, biotechnology, anti-infective drug development, clinical microbiology, medical affairs, regulatory strategy and clinical research; Business consulting services in the field of non-dilutive funding, namely, identifying and advising clients on grant and government funding opportunities in the pharmaceutical and biotechnology industriesACTIVEAug 30, 2019
041Education services, namely, providing training, workshops, online courses, and webinars in the field of infectious diseases and critical care; Providing on-line courses of instruction in the field of infectious diseases and critical care via a website; Providing education courses in the field of infectious diseases and critical care offered through online, non-downloadable videos and instructor assistance; Education services, namely, providing non-downloadable webinars in the field of infectious diseases and critical care; Providing online non-downloadable publications in the nature of training materials in the field of infectious diseases and critical careACTIVEAug 30, 2019
042Technology advisory services related to drug development; Consulting services for others in the field of design, planning, and implementation project management of clinical trials, product development; Product development consulting in the field of pharmaceuticals; Pharmaceutical products development; Scientific research in the nature of conducting clinical trials for othersACTIVEAug 30, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 1, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 1, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance